Research
To understand the architectural make-up of human society and what sustains it can be complex and misleading. The green industrial revolution of 1936 reformed our traditional agricultural frameworks to a centralized chemically induced infrastructure that sets the stage for all modern-day food and nutritional assets. In the mist of global warming and food security breaches our nutritional value requirements have been systematically diluted with food and biological process engineering. Adversely these synthetic food and nutritional substitutes are not a sufficient value source. They inherently force the disintegration of cellular life ultimately ensuing their breakdown, followed by disease and human mortality.
At CH LABS, in collaboration with its research parent, CULMINATE H LABS, our sole purpose and focus is to elevate and extend human life via cellular nutrition and cellular optimization. This implies taking a vertical integrated approach that combines proteomics, biological thermodynamics, and bioenergetics with information energy conversion systems. Within this focal point our architecture is carefully built on 3 key pillars:
- A Genome library outlining the architecture of cellular building blocks & a register of each cell’s target specific nutrients.
- A map(s) & critical path on how to deliver these target specific nutrients to achieve optimal cell absorption & bioavailability.
- A library of formulas, protocols, & methods on how to produce cellular therapies and or nutritional products that nurture cells for optimal health and longevity.
OUR REVOLUTION
1979-1990;
The successful extraction and use of ultra filtrate peptides comprised of tissues and endocrine glads derived from embryonic ovine placenta stem cells.
1980-1995;
Effective hydrolysis reaction through macromolecules ruptures that increase increasing and actuate the appropriate enzymes, suitable pH and temperature variations to yield a mixture of potent and sophisticated amino acids.
1980-1997;
Optimal fragmentation through hydrolysis yielding a polypeptides, dipeptides and amnio acids in addition to their natural tissues which contain complex proteins (phosphor-proteins, nuclei-proteins, glycoproteins, lipoproteins and metabolic-proteins).
1981-2001;
Optimal yield of supplemental building block components: phosphorus compounds, nucleic acids, and nucleotides. All derived from carbohydrates and lipids, biological cofactors, trace elements and electrolytes, in addition to lysis protein derivatives.
1983-2001;
Comprehensive implementation of lysed-process resulting in optimal normalization of structure, physiology and the metabolism of a particular tissue or organ.
1979-2005;
Optimal cell and regeneration cocktail comprised of tissue / organ specific protein, amino acids, hydrolysates, vitamins, trace elements, minerals and herbal elements to complement and potentiate the function of the hydrolysates with the placenta stem cells.
1979-2005;
Successful implementation and administration of proteolytic enzymes to reduce a range of complex proteins, polypeptides and oligopeptides peptones in order to achieve maximum reach of amino acids.
REFERENCES & USE CASES
Center for Cellular Therapy & Cytoplasmic Information and Library Archive; Volume 1, 1076-1982, Cytoplasmic Biology, ovine placenta stem cells.
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; 2n.d Simposium Cellular Therapy, (1988).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 1, (1993).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 2, clinical trials, (1993).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Nestor E. Bravo, Irene A. Funai; Advances en plastic surgery and repair in the pre and post surgical procedures with molecular nutrition, (1994).
Dr. Santiago Caleque; brief clinical overview in the following cellular and molecular therapies via the use of thymus glands and placenta cotyledon tissues for the mediation of biological conditions, (1996).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; a 13 part system outlining molecular therapies specific to organ tissues and their optimal function, (1997).
Dr. Santiago Caleque, Dr. Aaron Erenfryd; cellular and organ therapies via macromolecular nutrition, (1997).
Dr. Santiago Caleque; pluripotent cells revitalization via macromolecular tissue therapies, (1998).
Dr. Santiago Caleque; therapy protocols in molecular tissues, (1999).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; blastema tissues, the fundamentals of mesenchymal stem cells (2000).
Dr. Santiago Caleque, Dr. Ruben O. Muhlberger, Dr. Eduardo Arganaras; prophylaxis for aging and metabolic conditions via molecular tissue therapies, (2000).
Dr. Hayde Losa; delivery absorption of hydrolyzed molecular tissue cocktails, (2009).
Dr. Eradio Ignacio Minotti; Advances In Cellular Biology, the human genome, cell Life, & modern integrated Health, (2015).
Juan Carlos Rodriguez, Calixto Vallejo; Cellular Optimization; identifying cellular negentropy via ATP levels in pharmacodynamic assays, (2020).
Juan Carlos Rodriguez, Calixto Vallejo; Cellular Optimization; towards cellular resonance in Maxwell’s Demon, (2021).
Juan Carlos Rodriguez, Calixto Vallejo; Biological Thermodynamics as information energy conversion, (2022).
Juan Carlos Rodriguez; Calixto Vallejo; Cellular Nutrition the foundation for bioenergetics, (2022).
Juan Carlos Rodriguez; Calixto Vallejo; Using existing cellular structures to generate new proteins, (2023).
Juan Carlos Rodriguez; Calixto Vallejo; Mitochondria management of information energy conversation, (2023).
Juan Carlos Rodriguez; Calixto Vallejo; Cellular Negentropy, the mathematics of harmonic resonance, (2023).
Juan Carlos Rodriguez; Calixto Vallejo; Cellular Negentropy in a capsule, (2024).
